20 Things to Know about Epilepsy

Members of the UC Epilepsy Center (from left): Mark Callow, MD, Heather McKee, MD, Michael Privitera, MD, Brian Moseley, MD, and Jennifer Cavitt, MD. Photos by Cindy Starr.

Members of the UC Epilepsy Center (from left): Mark Callow, MD, Heather McKee, MD, Michael Privitera, MD, Brian Moseley, MD, and Jennifer Cavitt, MD. Photos by Cindy Starr.

Six fellowship-trained neurologists from the Epilepsy Center at the University of Cincinnati Gardner Neuroscience Institute recently shared their expertise at the center’s annual symposium for patients at the Daniel Drake Center for Post-Acute Care. The epileptologists were:

Michael Privitera, MD, director of the UC Epilepsy Center
David Ficker, MD, associate director of the UC Epilepsy Center
Mark Callow, MD
Jennifer Cavitt, MD
Heather McKee, MD
Brian Moseley, MD

Here are 20 facts drawn from their presentations about this common neurological condition.

1. A person has epilepsy if he or she experiences a seizure and is found upon evaluation to be at significant risk of having a second seizure.

2. There are two basic types of seizures, focal and generalized. Focal seizures start in one specific spot, while generalized seizures start in all areas of the brain.

3. A generalized, tonic-clonic seizure is also sometimes called a grand mal seizure.

4. Up to 3 million Americans have epilepsy, and there are 70,000 to 130,000 new cases in the United States each year.

5.  The risk of developing epilepsy peaks in childhood and again in the elderly.

6.  Thirty percent of epilepsy cases have a known cause, such as a tumor, a prior brain infection, a vascular abnormality or trauma. Seventy percent of epilepsy cases have no known cause.

David Ficker, MD, associate director of the UC Epilepsy Center.

David Ficker, MD, associate director of the UC Epilepsy Center.

7. There are 23 drugs available to treat epilepsy. The newest is Brivaracetam, approved in 2016.

8. Epidiolex, a new drug made from purified cannabidiol, may be approved for the treatment of severe forms of epilepsy as early as 2018.

9. Medications can completely control seizures in 60 to 70 percent of people who take them.

10. Although old epilepsy drugs work, newer drugs have new mechanisms of action and have fewer side effects and fewer interactions with other medications. As a result, patients require fewer labs to monitor liver and kidney function.

11. Among people diagnosed with epilepsy, 47 percent will be seizure-free after being treated with their first medication. Another 13 percent will be seizure-free after being prescribed a second medication. A third medication will work for only 1 percent of patients, while a combination of two medications will work for 3 percent.

12. Patients who still have seizures after trying two different medications should be seen at a comprehensive epilepsy center that has epilepsy experts and advanced technologies to accurately diagnose and treat epilepsy.

13. People whose seizures are not controlled by medications are said to have refractory epilepsy. Epilepsy specialists may treat them with surgery, implanted devices or a strict dietary regimen.

14. There are more than one million women of reproductive age with epilepsy in the United States. They give birth to 24,000 babies each year.

15. The risk of birth defects is 1 to 2 percent in the general population, compared to 2 to 9 percent for pregnant women who have epilepsy. The risk may be higher for pregnant women who are on multiple anti-epileptic medications.

16. The risk of birth defects is 19 percent for pregnant women with epilepsy who take a combination of antiepileptic drugs when that combination includes valproate.

17. There are risks to having continued seizures.  They include the risk of injury, cognitive decline, social and psychological impairment and SUDEP (sudden unexplained death in epilepsy). Doctors do not know what causes SUDEP.

18. The American Academy of Neurology recommends surgery as the most effective treatment for patients with refractory epilepsy whose seizures begin in the temporal lobe. In patients whose seizure focus can be removed, seven in 10 can expect to be seizure-free.

19. Among people with epilepsy, up to 30 to 35 percent have depression (compared to 6 to 7 percent in the general population) and from 25 to 50 percent have anxiety (compared to 18 percent of the general population).

20. Depression and anxiety can be effectively treated with medications in most people with epilepsy, without significant risk of increasing seizures.

This entry was posted in UC Gardner Neuroscience Blog. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • Sign up for our newsletter!
  • UCNI Weekly Blog
  • Hope Stories

    • Dick’s Story: Ischemic Stroke

      Dick's Story: Ischemic Stroke As a firefighter who attends regular EMS drills, Dick Koeniger was well versed in the signs and symptoms of stroke. While driving home with a friend one evening last June, he suddenly noticed that his peripheral vision was slightly impaired....
    • Janis’s Story: Levodopa Pump for Parkinson’s Disease

      Janis's Story: Levodopa Pump for Parkinson's Disease When Janis Yelton gratefully enrolled in a ground-breaking study at the University of Cincinnati Gardner Neuroscience Institute, she was wracked by pain from advanced Parkinson’s disease, taking 32 pills a day, and no longer able to work. Years later, Janis still...
    • Richard’s Story: Ruptured Aneurysms

      Richard's Story: Ruptured Aneurysms Almost three years ago, Richard “Dick” Watson, MD, found himself in an unfamiliar position for a doctor: lying on the operating table instead of standing over it. He didn’t know it at the time, but it was the beginning of...
    • Mary Ann’s Story: Cervical Dystonia

      Mary Ann’s Story: Cervical Dystonia Mary Ann, a registered nurse, was the first to notice that her head was tilting ever so slightly to the left. She was able to ignore it for a while, but over time the tilt became more obvious and disfiguring....
    • Paula’s Story: Clot-Retriever Success

      Paula's Story: Clot-Retriever Success No one ever wants to suffer a stroke. But when Paula suffered a major, life-threatening stroke in September 2013 while working at a local deli, one might say that her timing was perfect. First and foremost, Paula got to the University...
    • John’s Story: Epilepsy

      John's Story: Epilepsy In golf they call it a “bad lie.” A golfer strikes the ball, hoping to place it in a comfortable location on the fairway or the green, but the ball winds up somewhere else entirely – on the side of a...
    • Troy’s Story: Proton Therapy for Brain Cancer

      Troy's Story: Proton Therapy for Brain Cancer Troy Witt, 65, a London, Kentucky resident and a self-proclaimed "country boy,” says he loves his family, fishing, woodworking and riding on his tractor. But all of these activities have been put on hold since spring 2016 when Witt’s...
    • Lynne’s Story: Brain Metastasis

      Lynne's Story: Brain MetastasisSemiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Amy’s Story: A Battle With MS

      Amy's Story: A Battle With MSIn retrospect, multiple sclerosis had probably been stalking Amy for a long time. She had suffered from chronic headaches in high school, and her seasonal allergies had been over the top. Then, in her mid-30s, the busy wife and mother...
    • Sunny’s Story: A New MS Family

      Sunny's Story: A New MS Family As Sunny knows, one does not defeat multiple sclerosis. The disease is here today, and it is still here tomorrow. But with help from skilled,...